Lilly Asia Ventures

Domain expertise, global resource, long-term capital

• Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm, with offices in Shanghai, Hong Kong, and Palo Alto
• Our vision is to become the trusted partner for exceptional entrepreneurs seeking smart capital and to build great companies developing breakthrough products that treat diseases and improve human health
• Our Philosophy We are long-term thinkers who bet on people, products and quality science
• Investment Scope biopharmaceuticals, human therapeutics, medical devices, and diagnostics

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm, with offices in Shanghai, Hong Kong, and Palo Alto. Our vision is to become the trusted partner for exceptional entrepreneurs seeking smart capital and to build great companies developing breakthrough products that treat diseases and improve human health.

We are long-term thinkers who bet on people, products and quality science.

biopharmaceuticals, human therapeutics, medical devices, and diagnostics

Room 2909-14, 168 Hubin Road, Huangpu District, Shanghai, China

Room 606-7, St George's Building, 2 Ice House Street, Central, Hong Kong 2735 Sand Hill Road, Suite 210 Menlo Park, CA 94025